Evidence map›Paper›PMID 38293936›Full record

ArticleJournal of the American Heart Association2024

Magnetic Resonance Imaging Tissue Signatures Associated With White Matter Changes Due to Sporadic Cerebral Small Vessel Disease Indicate That White Matter Hyperintensities Can Regress.

Angela C C Jochems, Susana Muñoz Maniega, Una Clancy, Carmen Arteaga, Daniela Jaime Garcia, Francesca M Chappell, Will Hewins, Rachel Locherty, Ellen V Backhouse, Gayle Barclay and 12 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Angela C C JochemsCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0001-7392-3066
Susana Muñoz ManiegaCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0001-5185-6384
Una ClancyCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-8062-7537
Carmen ArteagaCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0003-2424-7123
Daniela Jaime GarciaCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.
Francesca M ChappellCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-7742-1757
Will HewinsCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0009-0006-1373-9068
Rachel LochertyCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0003-0297-6851
Ellen V BackhouseCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0001-5083-9945
Gayle BarclayEdinburgh Imaging Facility, Royal Infirmary of Edinburgh Edinburgh United Kingdom.
Charlotte JardineEdinburgh Imaging Facility, Royal Infirmary of Edinburgh Edinburgh United Kingdom.ORCID 0009-0001-3732-4135
Donna McIntyreEdinburgh Imaging Facility, Royal Infirmary of Edinburgh Edinburgh United Kingdom.
Iona GerrishEdinburgh Imaging Facility, Royal Infirmary of Edinburgh Edinburgh United Kingdom.
Agniete KampaiteCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.
Eleni SakkaCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-7082-1168
Maria Valdés HernándezCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.
Stewart WisemanCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0001-6739-5797
Mark E BastinCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-0490-0845
Michael S StringerCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-3811-4439
Michael J ThrippletonCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0001-7858-9917
Fergus N DoubalCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-2769-3148
Joanna M WardlawCentre for Clinical Brain Sciences University of Edinburgh Edinburgh United Kingdom.ORCID 0000-0002-9812-6642

Funding

Chief Scientist Office ETM/326Medical Research Council MR/J006971/1The Dunhill Medical Trust R380R/1114Wellcome Trust
6 · The paper itself

Abstract

backgroundWhite matter hyperintensities (WMHs) might regress and progress contemporaneously, but we know little about underlying mechanisms. We examined WMH change and underlying quantitative magnetic resonance imaging tissue measures over 1 year in patients with minor ischemic stroke with sporadic cerebral small vessel disease. METHODS AND

resultsWe defined areas of stable normal-appearing white matter, stable WMHs, progressing and regressing WMHs based on baseline and 1-year brain magnetic resonance imaging. In these areas we assessed tissue characteristics with quantitative T1, fractional anisotropy (FA), mean diffusivity (MD), and neurite orientation dispersion and density imaging (baseline only). We compared tissue signatures cross-sectionally between areas, and longitudinally within each area. WMH change masks were available for N=197. Participants' mean age was 65.61 years (SD, 11.10), 59% had a lacunar infarct, and 68% were men. FA and MD were available for N=195, quantitative T1 for N=182, and neurite orientation dispersion and density imaging for N=174. Cross-sectionally, all 4 tissue classes differed for FA, MD, T1, and Neurite Density Index. Longitudinally, in regressing WMHs, FA increased with little change in MD and T1 (difference estimate, 0.011 [95% CI, 0.006-0.017]; -0.002 [95% CI, -0.008 to 0.003] and -0.003 [95% CI, -0.009 to 0.004]); in progressing and stable WMHs, FA decreased (-0.022 [95% CI, -0.027 to -0.017] and -0.009 [95% CI, -0.011 to -0.006]), whereas MD and T1 increased (progressing WMHs, 0.057 [95% CI, 0.050-0.063], 0.058 [95% CI, 0.050 -0.066]; stable WMHs, 0.054 [95% CI, 0.045-0.063], 0.049 [95% CI, 0.039-0.058]); and in stable normal-appearing white matter, MD increased (0.004 [95% CI, 0.003-0.005]), whereas FA and T1 slightly decreased and increased (-0.002 [95% CI, -0.004 to -0.000] and 0.005 [95% CI, 0.001-0.009]).

conclusionsQuantitative magnetic resonance imaging shows that WMHs that regress have less abnormal microstructure at baseline than stable WMHs and follow trajectories indicating tissue improvement compared with stable and progressing WMHs.

Indexed as

Cerebral Small Vessel DiseasesWhite MatterAgedBrainDiffusion Magnetic Resonance ImagingFemaleHumansMagnetic Resonance ImagingMalecerebral small vessel diseasecerebrovascular diseaseimagingMRIwhite matter hyperintensity

Identifiers

PMID38293936
PMCPMC11056146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.